Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15513)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2015 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo M, Guo JY, Cao WK. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11815-11824 [PMID: 26557005 DOI: 10.3748/wjg.v21.i41.11815] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i41/11815.htm |
| Number | Citing Articles |
| 1 |
Yue Li, Zhipeng Yao, Tong Li, Hongliang Wang. A Cross-Sectional Survey on Nonhepatic Hyperglycemia in Intensive Care Unit, Heilongjiang Province, China. Journal of Translational Critical Care Medicine 2020; 2(2): 36 doi: 10.4103/jtccm.jtccm_29_20
|
| 2 |
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. International Journal of Molecular Sciences 2021; 22(13): 6921 doi: 10.3390/ijms22136921
|
| 3 |
Ahmed A. Sedik, Azza Hassan, Dalia O. Saleh. Neuromodulatory role of L-arginine: nitric oxide precursor against thioacetamide-induced-hepatic encephalopathy in rats via downregulation of NF-κB-mediated apoptosis. Environmental Science and Pollution Research 2023; 30(35): 84791 doi: 10.1007/s11356-023-28184-7
|
| 4 |
Mustafa Bayraktar, Ahmet Hacımüftüoğlu, Ufuk Okkay, Mehmet Nuri Koçak, Murat Kösedağ, Erdal Tekin, Muhammet Çelik, Irmak Ferah Okkay, Cemil Bayram, Muhammet Sait Ertuğrul, Selma Sezen. Use of bee venom in preventive medicine: An experimental hepatic encephalopathy study in rats. Veterinary Medicine and Science 2024; 10(1) doi: 10.1002/vms3.1336
|
| 5 |
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu. The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.595759
|
| 6 |
Wei-Wei Wang, Yu Zhang, Xiao-Bing Huang, Nan You, Lu Zheng, Jing Li. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
|
| 7 |
Bora Dinc, Ilker Onguc Aycan, Mutay Aslan, Necmiye Hadimioglu, Zeki Ertug, Abdullah Kisaoglu, Ismail Demiryilmaz. Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort Study. Transplantation Proceedings 2021; 53(1): 16 doi: 10.1016/j.transproceed.2020.04.1818
|
| 8 |
Noha F. Hassan, Mona R. El-Ansary, Amira R. El-Ansary, Mohamed A. El-Saied, Omnia S. Zaki. Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories. Biochemical Pharmacology 2024; 229: 116504 doi: 10.1016/j.bcp.2024.116504
|
| 9 |
Yu Jun Wong, Jing Hong Loo. Albumin therapy for hepatic encephalopathy: current evidence and controversies. Metabolic Brain Disease 2023; 38(5): 1759 doi: 10.1007/s11011-022-01002-8
|
| 10 |
Nisha Kajla. Comparison of Arterial vs Venous Ammonia Levels in Hepatic Encephalopathy
. AMEI's Current Trends in Diagnosis & Treatment 2020; 3(2): 59 doi: 10.5005/jp-journals-10055-0076
|
| 11 |
Quan Chen, Yu Zhang, Zhen‐Dong Yue, Hong‐Wei Zhao, Lei Wang, Zhen‐Hua Fan, Fu‐Quan Liu. High‐mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(8): 522 doi: 10.1002/jhbp.770
|
| 12 |
Bingjie Lu, Chao Wu, Nisma Lena Bahaji Azami, Dong Xie, Changqing Zhao, Wan Xu, Dengcheng Hui, Xi Chen, Runfei Sun, Jingru Song, Yongtong An, Kun Li, Huijun Wang, Guan Ye, Mingyu Sun. Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy. Biomedicine & Pharmacotherapy 2021; 135: 111084 doi: 10.1016/j.biopha.2020.111084
|
| 13 |
Rafaela Pinto Coelho Santos, Eliana Cristina de Brito Toscano, Milene Alvarenga Rachid. Anti-inflammatory strategies for hepatic encephalopathy: preclinical studies. Arquivos de Neuro-Psiquiatria 2023; 81(07): 656 doi: 10.1055/s-0043-1767819
|
| 14 |
Pierre Deltenre, Christian Labenz, Marcus Schuchmann. Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e1032 doi: 10.1097/MEG.0000000000002273
|
| 15 |
Himayat Ullah, Hossam Shabana, Mohamed Akl Rady, Eman Abdelsameea, Mohamed I. Youssef, Housam Ahmed Helmy, Ghulam Mustafa, Tamer Samir Abd Elghafar, Feras Almarshad, Abdulrahman Alshahrani, Mohamed Abdel-Samiee, Abdulmajeed Ahmed Alwadai, Hendawy Abdel-moety Zedan, Farag khalil, Mahmoud Osama Ahmed, Arafat Kassem, Marwa M. Omar, Shimaa Y. Kamel, Saad El Deen Mohamed El sheref, Mohamed Hassan Attia Hassan, Hind S. AboShabaan, Wagih Elgendy, Amr M. Zaghloul, Ibrahim Ghoniem Ramadan Mohamed, Esam Zayed, Amir Abdelghaffar, Galal Abdelhameed Aboufarrag, A.S. Seif, Hussein Ahmed Elmahdy, Ashraf Said, Ali Farahat, Hesham El-Sayed Lashin, Essam Elmahdi, Ahmed Abuamer. Hypokalemia as a responsible factor related with the severity of hepatic encephalopathy: a wide multination cross-sectional study. Annals of Medicine & Surgery 2023; 85(6): 2427 doi: 10.1097/MS9.0000000000000470
|
| 16 |
B. I. Ganiev. Some aspects of the pathogenesis of hepatic encephalopathy. Health care of Tajikistan 2022; (2): 27 doi: 10.52888/0514-2515-2022-353-2-27-32
|
| 17 |
Arijit Nath, Máté András Molnár, Attila Csighy, Kornélia Kőszegi, Ildikó Galambos, Klára Pásztorné Huszár, András Koris, Gyula Vatai. Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels. Medicina 2018; 54(6): 98 doi: 10.3390/medicina54060098
|
| 18 |
Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa, Masanori Furukawa, Shinya Sato, Hideto Kawaratani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World Journal of Gastroenterology 2017; 23(47): 8355-8366 doi: 10.3748/wjg.v23.i47.8355
Abstract(1270) |
Core Tip(1069) |
Full Article(HTML)(6231)
|
Full Article (PDF)-1677K(1020)
|
Full Article (Word)-2672K(324)
|
Audio-2315K(60)
|
Video (1-1)(10)
|
Peer-Review Report-133K(213)
|
Answering Reviewers-84K(223)
|
Supplementary Material-36K(270)
|
Times Cited (78)
|
Total Visits (18685)
|
Open
|
| 19 |
Long Cheng, Xiaoying Wang, Xueni Ma, Huimei Xu, Yifan Yang, Dekui Zhang. Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice. Pharmaceutical Biology 2021; 59(1): 555 doi: 10.1080/13880209.2021.1917625
|
| 20 |
Kensuke Kitsugi, Kazuhito Kawata, Hidenao Noritake, Takeshi Chida, Kazuyoshi Ohta, Jun Ito, Shingo Takatori, Maho Yamashita, Tomohiko Hanaoka, Masahiro Umemura, Moe Matsumoto, Takafumi Suda. Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation. Journal of Clinical Medicine 2023; 12(6): 2210 doi: 10.3390/jcm12062210
|
| 21 |
Mohamed M. Amin. Dietary Interventions in Liver Disease. 2019; : 31 doi: 10.1016/B978-0-12-814466-4.00003-3
|
| 22 |
Lu Lu, Chao Wu, Bing-jie Lu, Dong Xie, Zheng Wang, Nisma Lena Bahaji Azami, Yong-tong An, Hui-jun Wang, Guan Ye, Ming-yu Sun. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. Journal of Ethnopharmacology 2020; 249: 112301 doi: 10.1016/j.jep.2019.112301
|
| 23 |
Mitsuhiko Shibasaki, Takeshi Hatanaka, Yasushi Shimada, Tamon Nagashima, Masashi Namikawa, Shuichi Saito, Kenichi Hosonuma, Atsushi Naganuma, Daichi Takizawa, Hirotaka Arai, Takashi Kosone, Hitoshi Takagi, Ken Sato, Satoru Kakizaki, Toshio Uraoka. Efficacy and safety of rifaximin treatment in Japanese patients with hepatic encephalopathy. Kanzo 2020; 61(1): 1 doi: 10.2957/kanzo.61.1
|
| 24 |
Maria Eduarda Rocha França, Renata Kelly Luna Gomes Ramos, Wilma Helena Oliveira, Eduardo Duarte-Silva, Shyrlene Meyre Rocha Araújo, Deniele Bezerra Lós, Christina Alves Peixoto. Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy. Toxicology and Applied Pharmacology 2019; 379: 114673 doi: 10.1016/j.taap.2019.114673
|
| 25 |
Juan José García Martínez, Karim Bendjelid. Artificial liver support systems: what is new over the last decade?. Annals of Intensive Care 2018; 8(1) doi: 10.1186/s13613-018-0453-z
|
| 26 |
Gamal Shiha, Nasser Mousa. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.88231
|
| 27 |
S. D. Podymova. New approaches to the pathogenesis, clinic, and treatment of hepatic encephalopathy. Terapevticheskii arkhiv 2021; 93(2): 236 doi: 10.26442/00403660.2021.02.200613
|
| 28 |
Rehab Nady, Rasha R. Ahmed, Nadia Moustafa, Manal Abdul-Hamid. TNF-α blockage by etanercept restores spatial learning and reduces cellular degeneration in the hippocampus during liver cirrhosis. Tissue and Cell 2023; 85: 102249 doi: 10.1016/j.tice.2023.102249
|
| 29 |
Igor de Sousa Oliveira, Bárbara Prado de Albuquerque, Hugo Tomé de Souza Lima, Lara Bianca Soares Brandão, Lia Maki Hatisuka Imai, Mara Georgia de Sousa Lima, Mariana Presot Elias, Samanta Pereira Teodoro, Weverton Flôr Patrício, Gilberto Loiola de Vasconcelos. Tratamento e fatores preditivos de prognóstico do paciente com Encefalopatia Hepática (HE). Revista Científica Multidisciplinar Núcleo do Conhecimento 2020; : 95 doi: 10.32749/nucleodoconhecimento.com.br/saude/preditivos-de-prognostico
|
| 30 |
Guihua Fang, Shuna Liu, Bin Liu. Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03184-0
|
| 31 |
Mozhgan Ghobadi Pour, Naser Mirazi, Hojatollah Alaei, Maryam Radahmadi, Ziba Rajaei, Alireza Monsef Esfahani. The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats. BioImpacts 2020; 10(3): 177 doi: 10.34172/bi.2020.22
|
| 32 |
Hassan Azhari, Mark G. Swain. Role of Peripheral Inflammation in Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology 2018; 8(3): 281 doi: 10.1016/j.jceh.2018.06.008
|
| 33 |
Elina G. Manzhalii, Tetyana M. Falalyeyeva, Valentyna O. Moyseyenko, Ralf Weiskirchen, Wolfgang Stremmel. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?. Digestive Diseases 2022; 40(2): 232 doi: 10.1159/000516412
|
| 34 |
Kok Ban Teh, Jing Hong Loo, Yew Chong Tam, Yu Jun Wong. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis. Digestive and Liver Disease 2021; 53(7): 817 doi: 10.1016/j.dld.2021.04.030
|
| 35 |
J.B. Medina, N.S. Andrade, F. de Paula Eduardo, L. Bezinelli, J.B. Franco, M. Gallottini, P.H. Braz-Silva, K.L. Ortega. Bleeding during and after dental extractions in patients with liver cirrhosis. International Journal of Oral and Maxillofacial Surgery 2018; 47(12): 1543 doi: 10.1016/j.ijom.2018.04.007
|
| 36 |
Arijit Nath, Gokce Haktanirlar, Áron Varga, Máté András Molnár, Krisztina Albert, Ildikó Galambos, András Koris, Gyula Vatai. Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina 2018; 54(2): 18 doi: 10.3390/medicina54020018
|
| 37 |
Bogdan A. Stana, Evelina Moraru. Hepatic encephalopathy - current considerations. Pediatru.ro 2019; 2(54): 24 doi: 10.26416/Pedi.54.2.2019.2435
|
| 38 |
E. G. Manzhaliy, O. V. Virchenko, T. D. Nykula, V. V. Bondur, V. O. Moyseyenko, A. Yu. Kondaurova. Залежність тяжкості депресії у хворих з печінковою енцефалопатією від рівня цитокінів. Likarska sprava 2016; (5-6): 56 doi: 10.31640/LS-2016(5-6)10
|
| 39 |
Heba M. A. Khalil, Islam A. Khalil, Asmaa K. Al-Mokaddem, Marwa Hassan, Riham A. El-Shiekh, Hesham A. Eliwa, Azza M. Tawfek, Walaa H. El-Maadawy. Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model. Drug Delivery and Translational Research 2023; 13(1): 252 doi: 10.1007/s13346-022-01181-y
|
| 40 |
Teresa Rubio, Vicente Felipo, Sonia Tarazona, Roberta Pastorelli, Desamparados Escudero-García, Joan Tosca, Amparo Urios, Ana Conesa, Carmina Montoliu. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80941-7
|
| 41 |
Mayra López‐Cervantes, Andrés Quintanar‐Stephano, Sarael Alcauter‐Solórzano, Rogelio Hernández‐Pando, Raúl Aguilar‐Roblero, Deisy Gasca‐Martínez, Juan J. Ortíz, Olivia Vázquez‐Martínez, Cecilia Ximénez‐Camilli, Mauricio Díaz‐Muñoz. Cerebellar spongiform degeneration is accompanied by metabolic, cellular, and motor disruption in male rats with portacaval anastomosis. Journal of Neuroscience Research 2021; 99(9): 2287 doi: 10.1002/jnr.24853
|
| 42 |
Motoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, Nagisa Hara, Kyoko Yoshikawa, Hideaki Tanaka, Akiko Eguchi, Norihiko Yamamoto, Kazushi Sugimoto, Yoshinao Kobayashi, Hiroshi Hasegawa, Yoshiyuki Takei. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients. Metabolic Brain Disease 2016; 31(5): 1151 doi: 10.1007/s11011-016-9862-6
|